Zepbound Overdose or Double Dose: What to Do Now

Editorial evidence status: This page was reconciled to the current 2026 FDA label and Poison Control guidance on August 29, 2026. Medical review is pending. It provides a triage record, not individualized toxicology treatment.

Take the Action Before Solving the Math

The current FDA label is direct: in an overdosage, contact the Poison Help Line at 1-800-222-1222 or a medical toxicologist for management recommendations [1]. Poison Control provides the same immediate route by phone or through webPOISONCONTROL [2].

Do not wait to see whether nausea appears. The important facts are the exact product, intended dose, possible amount delivered, device, timing, symptoms, co-medications, and who took it. A toxicology professional can interpret those facts together.

Call emergency services now for trouble breathing, swelling of the face or throat, collapse, seizure, inability to wake, severe confusion, or another immediately life-threatening reaction. Do not drive yourself if you are impaired.

Dose-Error Triage Record

Gather what you can without delaying the call.

This record is useful precisely because it avoids a fake universal threshold. Two people with the same nominal extra dose can have different risks based on co-medications, symptoms, health conditions, and uncertainty about delivery.

What the FDA Label Says About Overdose

The label does not name a Zepbound antidote or publish a home-treatment protocol. Its operative standard is: "Appropriate supportive treatment should be initiated according to the patient’s clinical signs and symptoms" [1]. This is the FDA-approved prescribing information speaking, not a HealthRX.com treatment instruction. The label also says observation and treatment may be needed, taking tirzepatide's approximately five-day half-life into account [1].

That long half-life does not mean symptoms will last exactly five days or that everyone must be observed for the same period. A half-life describes how exposure declines, not a discharge timer. Poison Control or the treating team determines the necessary setting and duration.

Do not induce vomiting. Do not take extra insulin, glucose-lowering medicine, anti-nausea medicine, laxatives, or large fluid amounts to "cancel" the dose unless a clinician or toxicologist who knows the case directs it. Do not use another person's glucose plan.

Symptoms the Team Will Ask About

Gastrointestinal symptoms and dehydration

Nausea, diarrhea, vomiting, constipation, abdominal pain, and dyspepsia are among Zepbound's common labeled adverse reactions [1]. With an extra dose, the treating team will care about severity, repeated vomiting, ability to keep fluids down, urine output, dizziness, and worsening abdominal pain.

The label warns about acute kidney injury related to adverse reactions that can cause volume depletion. Someone with kidney disease, a diuretic, or a fluid restriction should not follow a generic instruction to drink a fixed volume.

Low glucose risk with other medicines

Zepbound can increase hypoglycemia risk when used with insulin or an insulin secretagogue such as a sulfonylurea [1]. Sweating, shakiness, confusion, unusual behavior, weakness, seizure, or loss of consciousness can be warning signs. Follow the person's established emergency glucose plan while seeking immediate professional guidance; do not invent a new insulin adjustment.

Severe abdominal pain or hypersensitivity

Persistent severe abdominal pain, especially with vomiting, requires prompt evaluation because pancreatitis and gallbladder disease are labeled risks. Trouble breathing, facial or throat swelling, widespread hives, collapse, or rapidly worsening allergic symptoms are emergencies.

What Published Exposure Data Can and Cannot Answer

A 2025 retrospective cohort described 152 GLP-1 or dual GLP-1/GIP agonist exposures managed in emergency departments across three poison centers [3]. It can help toxicologists recognize patterns, but it combined products, excluded some important exposure types, and does not establish a home-management threshold for a specific Zepbound dose. National poison-center surveillance likewise shows that therapeutic errors are common, but surveillance counts cannot predict one person's outcome [4].

That is why this page does not turn a milligram total into a green, amber, or red score. The current label and poison-center pathway remain more applicable to the immediate decision.

Double Dose, Early Dose, Partial Dose, and Missed Dose Are Different

A confirmed second full dose is not the same as taking the weekly dose one day early. An uncertain injection is not proof that no medicine was delivered. A missed dose is different again.

The routine missed-dose rule says that a missed Zepbound dose may be taken within four days, or 96 hours. After more than four days, it should be skipped and the regular schedule resumed. The label also requires at least three days, or 72 hours, between doses [1]. Those rules help manage an ordinary missed dose. They are not permission to self-manage a suspected double dose.

If a device leaked, stopped, or appeared to deliver only part of a dose, do not automatically inject again. Record what happened and contact the pharmacist, prescriber, manufacturer device-support channel, or Poison Control based on the possibility of excess exposure and any symptoms.

For future missed-dose decisions, use the Zepbound missed-dose guide. If a longer interruption has already occurred, the Zepbound restart guide explains why the label's single missed-dose rule does not establish a universal restart dose.

What Happens After the First Call

Poison Control or the treating team may ask you to monitor at home, obtain glucose readings, seek urgent evaluation, or call emergency services. The answer depends on the record above, not a website severity score.

If evaluation is recommended, bring the medication and device if it is safe to do so. Do not discard the pen or vial until the situation is resolved. Write down the advice, the time of the call, the next scheduled dose, and who will decide whether that dose is held or changed.

An adverse event or device problem can also be reported to FDA MedWatch after immediate safety needs are addressed. Reporting does not replace Poison Control or emergency care.

Preventing a Repeat Without Blame

Dose errors often come from a changed injection day, two people sharing responsibility, a confusing device, a partial-dose concern, or a schedule that was not recorded. A simple prevention record can include:

• one named person responsible for confirming the weekly dose;
• a single calendar entry made immediately after injection;
• the exact strength and device stored with the schedule;
• a rule not to repeat an uncertain injection before speaking with a pharmacist or prescriber; and
• a written missed-dose instruction from the current label.

Do not share a Zepbound pen between people. The current label also includes device-specific instructions that should be read for the exact presentation dispensed [1].

Bottom Line

The evidence-supported response to a suspected Zepbound overdose is not a home antidote or a universal symptom timeline. It is immediate poison-center or medical-toxicology guidance, a precise dose-error record, symptom-based supportive care, and enough observation for the actual case.